Uni-Bio Science Group: 2021 Interim Results
Successful Turnaround to Profit-making with Record-High Turnover Expanding R&D Activity in Nanobody Drug to Diversify Product Portfolio HONG KONG SAR – EQS Newswire – 27 August 2021 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its interim results for six months ended 30 June 2021 (the “Period”), as well […]